levodopa has been researched along with Anxiety Neuroses in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Cui, S; Du, JJ; Fu, R; Gao, C; Huang, P; Lin, Y; Wang, T; Zhou, H | 1 |
| Choi, HS; Hwang, BY; Lee, CK; Lee, MK; Shin, KS; Zhao, TT | 1 |
| Danysz, W; Dekundy, A; Gravius, A; Morè, L; Nagel, J; Pietraszek, M | 1 |
| Byrne, GJ; Dissanayaka, NN; Marsh, R; Matheson, S; Mellick, GD; O'Sullivan, JD; Sellbach, A; Silburn, PA | 1 |
| Ishizu, H; Kuroda, S; Terada, S | 1 |
| Berry-Kravis, E; Hagerman, PJ; Hagerman, RJ; Hall, DA; Leehey, MA; Rice, CD | 1 |
| Alonso-Navarro, H; Jiménez-Jiménez, FJ | 1 |
| de Haan, RJ; Post, B; Speelman, JD | 1 |
| Coignet, A; de Recondo, J; Rondot, P; Ziegler, M | 1 |
| Bennett, G; Walsh, K | 1 |
| Heuser, IJ; Juncos, JL; Stein, MB; Uhde, TW | 1 |
2 review(s) available for levodopa and Anxiety Neuroses
| Article | Year |
|---|---|
[Parkinson's disease].
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Cognition Disorders; Depressive Disorder; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Risk Factors; Selective Serotonin Reuptake Inhibitors | 2003 |
Parkinson's disease and anxiety.
Topics: Aged; Anti-Anxiety Agents; Antiparkinson Agents; Anxiety Disorders; Humans; Levodopa; Parkinson Disease; Prevalence; Psychomotor Disorders | 2001 |
9 other study(ies) available for levodopa and Anxiety Neuroses
| Article | Year |
|---|---|
Clinical characteristics and quality of life in Chinese patients with multiple system atrophy.
Topics: Antiparkinson Agents; Anxiety Disorders; Asian People; China; Cognitive Dysfunction; Depressive Disorder; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Quality of Life | 2018 |
Effects of gypenosides on anxiety disorders in MPTP-lesioned mouse model of Parkinson's disease.
Topics: Animals; Anti-Anxiety Agents; Antiparkinson Agents; Anxiety Disorders; Behavior, Animal; Brain; Dopamine; Dopaminergic Neurons; Ethanol; Gynostemma; Levodopa; Male; Maze Learning; Mice, Inbred C57BL; Neuroprotective Agents; Neuropsychological Tests; Parkinsonian Disorders; Phytotherapy; Plant Extracts; Serotonin; Water | 2014 |
Investigation on tolerance development to subchronic blockade of mGluR5 in models of learning, anxiety, and levodopa-induced dyskinesia in rats.
Topics: Animals; Antiparkinson Agents; Anxiety Disorders; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Glutamic Acid; Learning Disabilities; Levodopa; Male; Maze Learning; Memory Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Synaptic Transmission; Thiazoles | 2008 |
Anxiety disorders in Parkinson's disease: prevalence and risk factors.
Topics: Aged; Antiparkinson Agents; Anxiety Disorders; Cognition Disorders; Comorbidity; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Functional Laterality; Gait; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Posture; Prevalence; Risk Factors; Severity of Illness Index | 2010 |
Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome.
Topics: Adrenergic beta-Antagonists; Aged; Anxiety Disorders; Benzodiazepines; Carbidopa; Central Nervous System Agents; Cerebellar Ataxia; Cholinesterase Inhibitors; Dopamine Agonists; Female; Fragile X Syndrome; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Neurologic Examination; Parkinsonian Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Tremor | 2006 |
Panic attack like episodes possibly associated with pramipexole therapy in Parkinson's disease.
Topics: Anxiety Disorders; Benzothiazoles; Carbidopa; Central Nervous System; Diazepam; Dopamine Agonists; Dose-Response Relationship, Drug; Female; GABA Agonists; Humans; Levodopa; Middle Aged; Panic Disorder; Parkinson Disease; Pramipexole; Self Administration | 2007 |
Clinical heterogeneity in newly diagnosed Parkinson's disease.
Topics: Adult; Age Distribution; Age of Onset; Aged; Aged, 80 and over; Anxiety Disorders; Cluster Analysis; Cohort Studies; Comorbidity; Depressive Disorder; Disability Evaluation; Disease Progression; Female; Humans; Immunity, Innate; Levodopa; Male; Middle Aged; Movement Disorders; Netherlands; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Quality of Life | 2008 |
Mental disorders in Parkinson's disease after treatment with L-DOPA.
Topics: Aged; Anxiety Disorders; Confusion; Delirium; Dementia; Depressive Disorder; Female; Hallucinations; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease | 1984 |
Anxiety disorders in patients with Parkinson's disease.
Topics: Adult; Aged; Anxiety Disorders; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1990 |